ORTINGLOBEPharmaceuticals
Ortin Global Ltd — Cash Flow Statement
₹13.56
-4.89%
Ortin Global Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -0.41 Cr | -4.79 Cr | -0.25 Cr | 2.02 Cr | — |
| Issuance Of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Capital Expenditure | -36000.00 | — | -20000.00 | -0.13 Cr | — |
| End Cash Position | 0.37 Cr | 0.46 Cr | -3.26 Cr | -3.92 Cr | — |
| Beginning Cash Position | 0.46 Cr | -3.26 Cr | -3.92 Cr | -5.47 Cr | — |
| Changes In Cash | -0.09 Cr | 3.72 Cr | 0.66 Cr | 1.55 Cr | — |
| Financing Cash Flow | 0.33 Cr | -3.49 Cr | 0.90 Cr | -0.47 Cr | — |
| Net Other Financing Charges | 1.88 Cr | -1.85 Cr | 0.07 Cr | 0.05 Cr | — |
| Interest Paid Cff | -27000.00 | -0.48 Cr | -0.40 Cr | -0.81 Cr | — |
| Net Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Issuance Payments Of Debt | -1.55 Cr | -1.16 Cr | 1.23 Cr | 0.29 Cr | — |
| Net Short Term Debt Issuance | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Long Term Debt Issuance | -1.55 Cr | -1.16 Cr | 1.23 Cr | 0.29 Cr | — |
| Investing Cash Flow | -36000.00 | 12.00 Cr | 82000.00 | -0.13 Cr | — |
| Net Investment Purchase And Sale | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net PPE Purchase And Sale | -36000.00 | 12.00 Cr | 82000.00 | -0.13 Cr | — |
| Purchase Of PPE | -36000.00 | — | -20000.00 | -0.13 Cr | 0.00 |
| Operating Cash Flow | -0.41 Cr | -4.79 Cr | -0.25 Cr | 2.15 Cr | — |
| Taxes Refund Paid | 0.00 | -1.29 Cr | 0.00 | 0.00 | — |
| Change In Working Capital | 0.41 Cr | 0.72 Cr | -0.78 Cr | 1.58 Cr | — |
| Change In Other Current Liabilities | -0.42 Cr | 0.09 Cr | -0.46 Cr | 1.51 Cr | — |
| Change In Other Current Assets | -0.64 Cr | -1.88 Cr | -0.04 Cr | 0.04 Cr | — |
| Change In Payable | -0.04 Cr | -1.47 Cr | 0.76 Cr | -0.55 Cr | — |
| Change In Inventory | 0.03 Cr | 2.55 Cr | -0.86 Cr | 0.09 Cr | — |
| Change In Receivables | 1.51 Cr | 1.65 Cr | -0.18 Cr | 0.68 Cr | — |
| Other Non Cash Items | 27000.00 | 0.48 Cr | 0.40 Cr | 0.81 Cr | — |
| Depreciation And Amortization | 0.01 Cr | 0.23 Cr | 0.25 Cr | 0.29 Cr | — |
| Depreciation | 0.01 Cr | 0.23 Cr | 0.25 Cr | 0.29 Cr | — |
| Net Income From Continuing Operations | -0.84 Cr | -7.08 Cr | -0.11 Cr | -0.53 Cr | — |
| Other Cash Adjustment Outside Changein Cash | — | -0.62 Cr | — | — | -1000.00 |
| Gain Loss On Investment Securities | — | 2.15 Cr | -88000.00 | — | — |
| Repurchase Of Capital Stock | — | — | — | 0.00 | -6.92 Cr |
| Common Stock Payments | — | — | — | 0.00 | -6.92 Cr |
| Effect Of Exchange Rate Changes | — | — | — | — | 0.00 |
| Sale Of Investment | — | — | — | — | 0.07 Cr |
| Purchase Of Investment | — | — | — | — | 0.00 |
| Pension And Employee Benefit Expense | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Ortin Global Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.